News About: Pharm. Industry


KRPMA activates to take part in KPMA

The KPMA decided to provide more opportunities to the foreign invested company organization, KRPMA to take part in the administration of KPMA for development of domestic pharmaceutical industry in such a globalization...

Drug industry expedited to restructuring by Government this year.

According to "99 major project promotion plan" reported by the MOHW, the MOHW will induce the local drug industry autonomously to make restructuring so as to eliminate duplicate and a lavish investment and unreasonabl...

Shareholder's meeting of most listed drug firms scheduled on Mar. 12.

23 listed pharmaceutical companies (fiscal year ended at Dec. 31) excluding the firms in process of court arbitration made schedules for their shareholder's meeting on March 12 and 19. 18 companies including Dong-A on...

50 billion Won sales targeted in 1999 by GlaxoWellcome Korea.

GlaxoWellcome Korea (President: Kim Jin-ho) established the company management objective this year aiming at a base construction of business profit ensuing the previous year by intensifying the sales organization and ...

1998 Sales growth of leading drug makers slow.

The sales of leading pharmaceutical manufacturers last year went up slow at merely 4% level of its growth over the previous year, YK Newletter survey reported, which was attributed largely to the nationwide ec...

Discount after sales transaction to cut or eliminate.

So far the drug company has traditionally provided so-called "Discount after sales" to the customer, a sort of allowance payable at the end of year or some time after the sales transaction. Since such allowance has be...

Insurance reimbursement policy of imported drugs painful to foreign pharmaceutical firms.

The government approved the insurance reimbursement for imported drugs to be implemented from July 1 at far lower prices than the level in current practice, and therefore foreign pharmaceutical firms raised its proble...

Survey on top executives over pharmaceutical economy (1)

Survey on top executives over pharmaceutical economy (1) Pharmaceutical business recovery to predict from year after next. YK Consultant surveyed "The pharmaceutical economic perspective this year and countermeasu...

Survey on top executives over pharmaceutical economy (1)

Survey on top executives over pharmaceutical economy (1) Pharmaceutical business recovery to predict from year after next. YK Consultant surveyed "The pharmaceutical economic perspective this year and countermeasu...

Survey on top executives over pharmaceutical economy (2)

With regard to the changes in drug distribution channel even after the implementation of the medical/pharmacy separation system, 62.9% of respondents indicated to intensify more the wholesale transaction, 11.4% to rei...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.